🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Élodie Montaudon

Université Paris Sciences et Lettres

ORCID: 0009-0002-5197-8300

Also affiliated with Institut Curie

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance”.

Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

Nature Cell Biology(2020)10.1038/s41556-020-0514-z
N/A
0.741DataRank · unranked
139 citations

Zhao Zhang, Yi‐Zhou Jiang, Pengya Xue, Hu Wang, Zhao Lai +16 more

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Nature Communications(2023)10.1038/s41467-023-42736-y
N/A
0.396DataRank · unranked
13 citations

Metin Çetįn, Meral Üner, Ünal Metin Tokat, Ioulia Chatzistamou, Pelin G. Ersan +8 more

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Science Translational Medicine(2020)10.1126/scitranslmed.aax2625
N/A
0DataRank · unranked
148 citations

Rania El Botty, Sophie Château‐Joubert, Ahmed Dahmani, Élodie Montaudon, Sophie Leboucher +29 more